New combo therapy aims to keep insulin flowing in young diabetes patients
NCT ID NCT06455319
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tests whether a two-step treatment can help young people with newly diagnosed type 1 diabetes keep making their own insulin. First, participants receive a low dose of anti-thymocyte globulin (ATG) to calm the immune system, followed by verapamil to reduce stress on insulin-producing cells. The goal is to preserve natural insulin production and lower blood sugar levels. The trial enrolls 60 people aged 6 to 35 who were diagnosed within the past 100 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Barbara Davis Center for Diabetes
RECRUITINGAurora, Colorado, 80045, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Florida
RECRUITINGGainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.